HoopCare provides a spectrum of preoperative services. The company offers cardiology evaluations, on-site nutrition counseling, and physical therapy. HoopCare also offers EKG, echocardiography, and stress testing services. In order to better control preoperative risk factors like anemia (iron deficiency) or quitting smoking, HoopCare has created a solution. The start-up has developed a 10-minute patient health questionnaire, and a machine learning algorithm analyzes the answers. This will take into account the obstetrics and surgical preoperative regimens.
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone. To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.
Resilience Care is building a software-based solution for cancer treatment providers and patients. By integrating a mobile application with a Remote Patient Monitoring platform, Resilience enhances care by personalizing, humanizing, and improving the care pathway. The mobile application aids individuals affected by cancer in managing treatment-related side effects and promoting self-care. Simultaneously, the Remote Patient Monitoring platform, classified as a Class IIa medical device, allows healthcare professionals to better understand and improve patient care.
Wandercraft develops and sells the first exoskeleton to walk self-balanced, providing a realistic gait without crutches or technical aids. Its first commercial version, Atalante, was CE-marked in 2019 and is sold to European rehab hospitals to improve gait re-learning treatments. As of June 2020, FDA approval is on the way. The company develops a slimmer, sleeker and agile Personal Mobility exo for daily life usage. Wandercraft is a full-stack company integrating competencies in algorithmics, AI, robotics, production, clinical, marketing and sales. Wandercraft's exo is the first realistic, autonomous walking device for the walking impaired and also likely the first bipedal walking robot to be a commercial product and not a lab prototype.
Lifen is a 160-person startup, based in Paris, whose ambition is to facilitate the deployment of digital solutions for hospitals, doctors and patients. Since 2015, Lifen has been simplifying the sharing of medical data and has quickly established itself as the leading MSSanté operator in France with more than 600 partner establishments. Every month, Lifen sends 2 million medical documents to 240,000 doctors. Creator of the FHIR France meetup and winner of the ANS interoperability prize 2020, Lifen's ambition is to use its expertise in interoperability with HIS to develop a platform that radically simplifies the technical integration and operational deployment of all types of digital solutions.
Ledger develops security and infrastructure solutions for cryptocurrencies as well as blockchain applications for individuals and companies, by leveraging a distinctive, proprietary technology. Launched in 2014, Ledger has designed an acclaimed line of hardware security devices quickly placing the company as a global leader on the market with 1,000,000 units sold in more than 165 countries. For enterprises and corporations, Ledger introduced the Vault: a fully managed SaaS solution addressing the need to safeguard a very large amount of multiple cryptocurrencies while mitigating both IT and physical assault threats. The company is also active on the industrial IoT market, leveraging its secure hardware technology to interface sensors and machines to smart contracts or blockchain based assets. Ledger is headquartered in Paris, has a production facility in Vierzon (France) and offices in San Francisco.
Savana is a medical company that has developed a scientific methodology that uses Artificial Intelligence (AI) to unlock all of the clinical value embedded in the free-text of Electronic Health Records (EHRs). Savana generates customized descriptive and predictive Deep Real World Evidence research studies using the world's largest AI-enabled, multi-language, multi-center research network. The company was designed by doctors for doctors and adheres to the highest privacy-by-design standards. Savana is a clinical research ecosystem that aims to advance personalized and precision medicine throughout the world. Savana was founded in 2014 and is headquartered in Madrid, Spain.
GLEAMER develops a suite of AI solutions for Radiology that encapsulate medical-grade expertise. The company wants to support imaging users to secure diagnoses for all patients at all times while improving efficiency. GLEAMER’s AI Companions are directly integrated into the users’ usual reading environment and act as an automated and transparent second reading to improve diagnostic accuracy in X-ray imaging. GLEAMER’s solutions are currently being used across 13 countries in more than 300 institutions.
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone. To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.
Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. They use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
Wellium is a medical teleconsultation solution allowing doctors to consult their patients online.
Bitfury is the leading full service Blockchain technology company and one of the largest private infrastructure providers in the blockchain ecosystem. Bitfury develops and delivers both the software and the hardware solutions necessary for businesses, governments, organizations and individuals to securely move an asset across the blockchain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.